UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039612
Receipt number R000045158
Scientific Title Effects of Apple polyphenol administration on the skin parameters induced by UV-irradiation
Date of disclosure of the study information 2020/12/31
Last modified on 2020/02/26 19:19:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Applephenon administration on the skin whitening and moisture condition

Acronym

Effects of Applephenon administration on the skin whitening and moisture condition

Scientific Title

Effects of Apple polyphenol administration on the skin parameters induced by UV-irradiation

Scientific Title:Acronym

Effects of Apple polyphenol administration on the skin parameters induced by UV-irradiation

Region

Japan


Condition

Condition

Skin pigmentation induced by UV-irradiation

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigated whether orally administrated apple polyphenols (Applephenon) could inhibit the pigmentation in the skin induced by UV irradiation in human clinical trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

erythema value, L value, melanin value, transepidermal water loss, moisture, questionnaire

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

12 weeks chronic administration of placebo tablets

Interventions/Control_2

12 weeks AP low-dose group (apple polyphenol 300 mg) per day

Interventions/Control_3

12 weeks AP high-dose group (apple polyphenol 600 mg) per day

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Female

Key inclusion criteria

20 and 39 years, and with skin phototype-II and -III

Key exclusion criteria

1)anti-oxidative products and supplements including vitamin c, CoQ10, polyphenol extracts such as grape seeds and green tea
2)subjects with skin trouble including atopic dermatitis and foods allergy
3)subjects with serious diseases such as diabetes, liver disease, kidney disease, heart disease
4)subjects with a medical condition requiring active management
5)subjects who wish to become pregnant during lactation, pregnancy or during the study period
6)subjects with irregular menstruation, those whose skin condition changes dramatically due to menstruation

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Otake
Middle name
Last name Yasuyuki

Organization

Asahi Breweries Co Ltd

Division name

Fundamental Research Laboratory

Zip code

302-0106

Address

1-21 Midori 1-chome, Moriya, Ibaraki

TEL

0297-46-1504

Email

yasuyuki.otake@asahibeer.co.jp


Public contact

Name of contact person

1st name Shoji
Middle name
Last name Toshihiko

Organization

Asahi Breweries Co Ltd

Division name

Fundamental Research Laboratory

Zip code

302-0106

Address

1-21 Midori 1-chome, Moriya, Ibaraki

TEL

0297-46-1504

Homepage URL


Email

toshihiko.shoji@asahibeer.co.jp


Sponsor or person

Institute

Others/Dermis Research Center

Institute

Department

Personal name



Funding Source

Organization

Asahi Breweries Co Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahi Breweries Co Ltd

Address

1-21 Midori 1-chome, Moriya, Ibaraki

Tel

0297-46-1504

Email

toshihiko.shoji@asahibeer.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

18372

Org. issuing International ID_1

Dermis Research Center

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 31 Day


Related information

URL releasing protocol

https://rd.asahigroup-holdings.com/research/report/23.html

Publication of results

Unpublished


Result

URL related to results and publications

https://rd.asahigroup-holdings.com/research/report/23.html

Number of participants that the trial has enrolled

65

Results

After UV-irradiation with 1.5 MED, changes in melanin value, L value, and erythema value over time were investigated. In each group, the erythema value, melanin value, and L value significantly increased after UV irradiation, but no difference was observed between the groups.

Results date posted

2020 Year 02 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

AP Low-dose group (n=21)
Age 34.2 4.29 y
MED 5323.7 478.0 mJ/cm2
AP high-dose group (n=20)
Age 35.2 3.89 y
MED 5471.1 499.7 mJ/cm2
Placebo group (n=18)
Age 34.1 4.08 y
MED 5247.0 531.7 mJ/cm2

Participant flow

Three subjects dropped out for personal reasons and three subjects failed to attend study visit for the measurement.

Adverse events

not detect

Outcome measures

melanin value, L value, erythema value

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2007 Year 01 Month 27 Day

Date of IRB

2007 Year 01 Month 26 Day

Anticipated trial start date

2007 Year 01 Month 29 Day

Last follow-up date

2007 Year 04 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 26 Day

Last modified on

2020 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045158


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name